Monitoring internal jugular venous oxygen levels noninvasively
The Development of Novel Noninvasive Internal Jugular Venous Oximetry
National Taiwan University Hospital · NCT06004466
This study is testing a new device that can noninvasively monitor oxygen levels in the veins of cancer patients during major surgeries to improve their care and reduce risks from invasive procedures.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 20 Years to 70 Years |
| Sex | All |
| Sponsor | National Taiwan University Hospital (other) |
| Locations | 1 site (Taipei) |
| Trial ID | NCT06004466 on ClinicalTrials.gov |
What this trial studies
This study focuses on developing a novel plethysmographic monitoring device that aims to continuously measure internal jugular venous oxygen saturation without the need for invasive central venous catheter placement. By integrating ultrasound imaging with local tissue optical parameter estimation and considering individual tissue characteristics, the device seeks to provide real-time monitoring of oxygen levels in cancer patients undergoing major surgeries. This approach could potentially reduce the risks associated with invasive procedures while improving patient care through continuous monitoring.
Who should consider this trial
Good fit: Ideal candidates for this study are cancer patients who are scheduled to undergo major surgeries requiring central venous catheter placement.
Not a fit: Patients with signs of infection, impaired liver or renal function, or heart failure may not benefit from this study.
Why it matters
Potential benefit: If successful, this device could significantly enhance patient safety and monitoring capabilities during and after major cancer surgeries.
How similar studies have performed: While the approach of noninvasive monitoring is promising, it is relatively novel and has not been extensively tested in similar studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing major cancer surgery that requires central venous catheter placement * Cancer patients undergoing totally implantable venous access device placement Exclusion Criteria: * Susepct infectious symptoms and signs (eg. white blood cell count count \>10000 ; fever \>38.3℃) * impaired liver functions (aspartate aminotransferase\> 100 U/L); impaired renal function (estimated glomerular filtration rate \<60 mL/min/1.73 m2) * heart failure, with New York Heart Associatation class 2 or more
Where this trial is running
Taipei
- National Taiwan University Hospital — Taipei, Taiwan (RECRUITING)
Study contacts
- Principal investigator: Chun-Yu Wu — National Taiwan University Hospital
- Study coordinator: Chun-Yu Wu
- Email: b001089018@tmu.edu.tw
- Phone: 886976653376
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Neoplasms